Cargando…
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
Antibody therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have been approved in many countries, with most being developed based on the original strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 has an exceptional ability to mutate under the pressure...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science China Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707277/ https://www.ncbi.nlm.nih.gov/pubmed/36443513 http://dx.doi.org/10.1007/s11427-022-2215-6 |